India has provided COVID-19 vaccines to 71 countries, over six new candidates in offing, says Harsh Vardhan

-

Union Health Minister Harsh Vardhan on Saturday announced that more than six coronavirus vaccines will come up in India. He also said that 1.84 crore COVID-19 vaccine doses have been administered to people so far, while 23 crore tests have been conducted.

"India has developed two vaccines, which have been given to 71 countries. Many more nations are seeking the vaccines, and these are not little-known  nations...Canada, Brazil and other developed countries are using Indian vaccines with a great zeal," he said.

"More than half a dozen vaccines are going to come up," he said. "Till Saturday morning, 1.84 crore vaccine shots have been given in the country and 20 lakh people were inoculated yesterday," the minister added.

He was speaking while inaugurating the new green campus of the National Institute of Research in Environmental Health near new Delhi.

Prime Minister Narendra Modi wants to create a new India to turn it into a 'vishwa guru' (world leader), he added.

"Respect science. There is a need to end politics over it (vaccine) given that it is a scientific fight, not a political one. That is why we should work unitedly," Vardhan
said. The efforts of our scientists are praiseworthy as due to their labour we have achieved all this. Year 2020, apart from being a COVID-19 year, will be remembered as the year of science and scientists, he added.

He said that initially there was only one laboratory in India for COVID-19 testing. "But we have 2,412 testing facilities now," he added. "We were the first in the world to isolate the coronavirus. We isolated its mutation. And our scientists helped the ICMR in vaccine. People have praised it (vaccine).

Some people tried to create confusion, but truth is unbeatable," he said.

Talking about the rising infection cases, the minister said this "disturbing trend" was due to the carelessness and misunderstanding. "People think that as the vaccine has come and all is well now," he said, while urging them to follow the COVID-19 rules for protection against the virus.



from Firstpost India Latest News https://ift.tt/3lcFAmE
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more